Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000165242 | SCV000215956 | likely benign | Hereditary cancer-predisposing syndrome | 2014-07-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000226776 | SCV000284048 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2024-11-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000420728 | SCV000527283 | likely benign | not specified | 2016-04-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000420728 | SCV000696138 | likely benign | not specified | 2019-09-03 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000165242 | SCV001346834 | likely benign | Hereditary cancer-predisposing syndrome | 2018-10-22 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000165242 | SCV002528714 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-12-16 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV003995408 | SCV004843278 | likely benign | Lynch syndrome | 2024-07-29 | criteria provided, single submitter | clinical testing |